Isolevuglandin-Modified Cardiac Proteins Drive CD4+ T Cell Activation in the Heart and Promote Cardiac Dysfunction.

Background: Despite the well-established association between T cell-mediated inflammation and non-ischemic heart failure (HF), the specific mechanisms triggering T cell activation during the progression of HF and the antigens involved are poorly understood. We hypothesized that myocardial oxidative stress induces the formation of isolevuglandin (IsoLG)-modified proteins that function as cardiac neoantigens to elicit CD4+ T cell receptor (TCR) activation and promote HF. Methods: We used transverse aortic constriction (TAC) in mice to trigger myocardial oxidative stress and T cell infiltration. We profiled the TCR repertoire by mRNA sequencing of intramyocardial activated CD4+ T cells in Nur77GFP reporter mice, which transiently express GFP upon TCR engagement. We assessed the role of antigen presentation and TCR specificity in the development of cardiac dysfunction using antigen presentation-deficient MhcII-/- mice, and TCR transgenic OTII mice that lack specificity for endogenous antigens. We detected IsoLG-protein adducts in failing human hearts. We also evaluated the role of reactive oxygen species (ROS) and IsoLGs in eliciting T cell immune responses in vivo by treating mice with the antioxidant TEMPOL, and the IsoLG scavenger 2-hydroxybenzylamine (2-HOBA) during TAC, and ex-vivo in mechanistic studies of CD4+ T cell proliferation in response to IsoLG-modified cardiac proteins. Results: We discovered that TCR antigen recognition increases in the left ventricle (LV) as cardiac dysfunction progresses, and identified a limited repertoire of activated CD4+ T cell clonotypes in the LV. Antigen presentation of endogenous antigens was required to develop cardiac dysfunction since MhcII-/- mice reconstituted with CD4+ T cells, and OTII mice immunized with their cognate antigen were protected from TAC-induced cardiac dysfunction despite the presence of LV-infiltrated CD4+ T cells. Scavenging IsoLGs with 2-HOBA reduced TCR activation and prevented cardiac dysfunction. Mechanistically, cardiac pressure overload resulted in ROS dependent dendritic cell accumulation of IsoLG-protein adducts which induced robust CD4+ T cell proliferation. Conclusions: Collectively, our study demonstrates an important role of ROS-induced formation of IsoLG-modified cardiac neoantigens that lead to TCR-dependent CD4+ T cell activation within the heart.

[1]  E. K. Weir,et al.  Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling. , 2019, Free radical biology & medicine.

[2]  K. Kaur,et al.  Heart Inflammation: Immune Cell Roles and Roads to the Heart. , 2019, The American journal of pathology.

[3]  M. Aronovitz,et al.  Distinct Phenotypes Induced by Three Degrees of Transverse Aortic Constriction in Mice , 2019, Scientific Reports.

[4]  M. Aronovitz,et al.  CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction. , 2019, JCI insight.

[5]  S. Prabhu,et al.  Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice , 2019, Redox biology.

[6]  Annet Kirabo,et al.  Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension. , 2018, Prostaglandins & other lipid mediators.

[7]  Sumanth D. Prabhu,et al.  CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload , 2018, JACC. Basic to translational science.

[8]  G. Hasenfuss,et al.  T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure , 2017, Scientific Reports.

[9]  M. Aronovitz,et al.  Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure , 2017, The Journal of experimental medicine.

[10]  Huan Wang,et al.  Role of bone marrow-derived CD11c+ dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy , 2017, Basic Research in Cardiology.

[11]  Xin Xu,et al.  CD28/B7 Deficiency Attenuates Systolic Overload-Induced Congestive Heart Failure, Myocardial and Pulmonary Inflammation, and Activated T Cell Accumulation in the Heart and Lungs , 2016, Hypertension.

[12]  V. Víctor,et al.  Role of ROS and RNS Sources in Physiological and Pathological Conditions , 2016, Oxidative medicine and cellular longevity.

[13]  G. Dubyak,et al.  T cell–intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis , 2016, Nature Immunology.

[14]  R. Karas,et al.  Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload–Induced Heart Failure , 2016, Journal of the American Heart Association.

[15]  R. Karas,et al.  Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure , 2015, Circulation. Heart failure.

[16]  D. Mann,et al.  Role of innate and adaptive immune mechanisms in cardiac injury and repair , 2015, Nature Reviews Immunology.

[17]  D. Harrison,et al.  DC isoketal-modified proteins activate T cells and promote hypertension. , 2014, The Journal of clinical investigation.

[18]  C. Vinel,et al.  CD4+ T Cells Promote the Transition From Hypertrophy to Heart Failure During Chronic Pressure Overload , 2014, Circulation.

[19]  O. Nureki,et al.  Toll‐Like Receptor‐2 Mediates Adaptive Cardiac Hypertrophy in Response to Pressure Overload Through Interleukin‐1β Upregulation via Nuclear Factor κB Activation , 2013, Journal of the American Heart Association.

[20]  C. Albert,et al.  Vitamin E Supplementation and the Risk of Heart Failure in Women , 2012, Circulation. Heart failure.

[21]  Nicole R. Cunningham,et al.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse , 2011, The Journal of experimental medicine.

[22]  D. Kass,et al.  Role of oxidative stress in cardiac hypertrophy and remodeling. , 2007, Hypertension.

[23]  D. Kass,et al.  Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. , 2005, The Journal of clinical investigation.

[24]  S. Yusuf,et al.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.

[25]  Ciriana Orabona,et al.  CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 , 2004, Nature Immunology.

[26]  Masahiro Ito,et al.  Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91phox , 2004, Circulation.

[27]  A. Shah,et al.  Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy , 2003, Circulation research.

[28]  E. Topol,et al.  Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials , 2003, The Lancet.

[29]  M. Hori,et al.  The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. , 2002, Journal of the American College of Cardiology.

[30]  D. Harrison,et al.  Immune activation caused by vascular oxidation promotes fibrosis and hypertension. , 2016, The Journal of clinical investigation.

[31]  S. Davies Modulation of protein function by isoketals and levuglandins. , 2008, Sub-cellular biochemistry.